Compare AbCellera Biologics Inc (ABCL) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Oklo Inc — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while Oklo Inc trades at $47.78 (market cap $8.74B). The key difference: Oklo Inc is far larger — about 2.9× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | OKLO | |
|---|---|---|
Market Cap | $2.99B | $8.74B |
Sector | Health | Technology |
52-Week High | $9.76 | $174.14 |
52-Week Low | $2.78 | $36.84 |
Enterprise Value | $2.58B | $6.28B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
